The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Pharmacovigilance (PV) and Drug Safety Software Market Research Report 2024
Synopsis
The global Pharmacovigilance (PV) and Drug Safety Software market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Pharmacovigilance (PV) and Drug Safety Software, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmacovigilance (PV) and Drug Safety Software.
Report Scope
The Pharmacovigilance (PV) and Drug Safety Software market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pharmacovigilance (PV) and Drug Safety Software market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmacovigilance (PV) and Drug Safety Software companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AB Cube
Sparta Systems, Inc.
Oracle Corporation
EXTEDO GmbH
Ennov Solutions, Inc.
ArisGlobal
United BioSource Corporation
Online Business Applications, Inc.
Segment by Type
Cloud based
On-premises
Segment by Application
Pharma and Biotech
Contract Research Organizations (CROs)
Business Process Outsourcing (BPO) Firms
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmacovigilance (PV) and Drug Safety Software companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Pharmacovigilance (PV) and Drug Safety Software market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Pharmacovigilance (PV) and Drug Safety Software, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmacovigilance (PV) and Drug Safety Software.
Report Scope
The Pharmacovigilance (PV) and Drug Safety Software market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pharmacovigilance (PV) and Drug Safety Software market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmacovigilance (PV) and Drug Safety Software companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AB Cube
Sparta Systems, Inc.
Oracle Corporation
EXTEDO GmbH
Ennov Solutions, Inc.
ArisGlobal
United BioSource Corporation
Online Business Applications, Inc.
Segment by Type
Cloud based
On-premises
Segment by Application
Pharma and Biotech
Contract Research Organizations (CROs)
Business Process Outsourcing (BPO) Firms
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmacovigilance (PV) and Drug Safety Software companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmacovigilance (PV) and Drug Safety Software Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Cloud based
1.2.3 On-premises
1.3 Market by Application
1.3.1 Global Pharmacovigilance (PV) and Drug Safety Software Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharma and Biotech
1.3.3 Contract Research Organizations (CROs)
1.3.4 Business Process Outsourcing (BPO) Firms
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmacovigilance (PV) and Drug Safety Software Market Perspective (2019-2030)
2.2 Pharmacovigilance (PV) and Drug Safety Software Growth Trends by Region
2.2.1 Global Pharmacovigilance (PV) and Drug Safety Software Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Pharmacovigilance (PV) and Drug Safety Software Historic Market Size by Region (2019-2024)
2.2.3 Pharmacovigilance (PV) and Drug Safety Software Forecasted Market Size by Region (2025-2030)
2.3 Pharmacovigilance (PV) and Drug Safety Software Market Dynamics
2.3.1 Pharmacovigilance (PV) and Drug Safety Software Industry Trends
2.3.2 Pharmacovigilance (PV) and Drug Safety Software Market Drivers
2.3.3 Pharmacovigilance (PV) and Drug Safety Software Market Challenges
2.3.4 Pharmacovigilance (PV) and Drug Safety Software Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmacovigilance (PV) and Drug Safety Software Players by Revenue
3.1.1 Global Top Pharmacovigilance (PV) and Drug Safety Software Players by Revenue (2019-2024)
3.1.2 Global Pharmacovigilance (PV) and Drug Safety Software Revenue Market Share by Players (2019-2024)
3.2 Global Pharmacovigilance (PV) and Drug Safety Software Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pharmacovigilance (PV) and Drug Safety Software Revenue
3.4 Global Pharmacovigilance (PV) and Drug Safety Software Market Concentration Ratio
3.4.1 Global Pharmacovigilance (PV) and Drug Safety Software Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmacovigilance (PV) and Drug Safety Software Revenue in 2023
3.5 Pharmacovigilance (PV) and Drug Safety Software Key Players Head office and Area Served
3.6 Key Players Pharmacovigilance (PV) and Drug Safety Software Product Solution and Service
3.7 Date of Enter into Pharmacovigilance (PV) and Drug Safety Software Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmacovigilance (PV) and Drug Safety Software Breakdown Data by Type
4.1 Global Pharmacovigilance (PV) and Drug Safety Software Historic Market Size by Type (2019-2024)
4.2 Global Pharmacovigilance (PV) and Drug Safety Software Forecasted Market Size by Type (2025-2030)
5 Pharmacovigilance (PV) and Drug Safety Software Breakdown Data by Application
5.1 Global Pharmacovigilance (PV) and Drug Safety Software Historic Market Size by Application (2019-2024)
5.2 Global Pharmacovigilance (PV) and Drug Safety Software Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Pharmacovigilance (PV) and Drug Safety Software Market Size (2019-2030)
6.2 North America Pharmacovigilance (PV) and Drug Safety Software Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Pharmacovigilance (PV) and Drug Safety Software Market Size by Country (2019-2024)
6.4 North America Pharmacovigilance (PV) and Drug Safety Software Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharmacovigilance (PV) and Drug Safety Software Market Size (2019-2030)
7.2 Europe Pharmacovigilance (PV) and Drug Safety Software Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Pharmacovigilance (PV) and Drug Safety Software Market Size by Country (2019-2024)
7.4 Europe Pharmacovigilance (PV) and Drug Safety Software Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharmacovigilance (PV) and Drug Safety Software Market Size (2019-2030)
8.2 Asia-Pacific Pharmacovigilance (PV) and Drug Safety Software Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Pharmacovigilance (PV) and Drug Safety Software Market Size by Region (2019-2024)
8.4 Asia-Pacific Pharmacovigilance (PV) and Drug Safety Software Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pharmacovigilance (PV) and Drug Safety Software Market Size (2019-2030)
9.2 Latin America Pharmacovigilance (PV) and Drug Safety Software Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Pharmacovigilance (PV) and Drug Safety Software Market Size by Country (2019-2024)
9.4 Latin America Pharmacovigilance (PV) and Drug Safety Software Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Size (2019-2030)
10.2 Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Size by Country (2019-2024)
10.4 Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AB Cube
11.1.1 AB Cube Company Detail
11.1.2 AB Cube Business Overview
11.1.3 AB Cube Pharmacovigilance (PV) and Drug Safety Software Introduction
11.1.4 AB Cube Revenue in Pharmacovigilance (PV) and Drug Safety Software Business (2019-2024)
11.1.5 AB Cube Recent Development
11.2 Sparta Systems, Inc.
11.2.1 Sparta Systems, Inc. Company Detail
11.2.2 Sparta Systems, Inc. Business Overview
11.2.3 Sparta Systems, Inc. Pharmacovigilance (PV) and Drug Safety Software Introduction
11.2.4 Sparta Systems, Inc. Revenue in Pharmacovigilance (PV) and Drug Safety Software Business (2019-2024)
11.2.5 Sparta Systems, Inc. Recent Development
11.3 Oracle Corporation
11.3.1 Oracle Corporation Company Detail
11.3.2 Oracle Corporation Business Overview
11.3.3 Oracle Corporation Pharmacovigilance (PV) and Drug Safety Software Introduction
11.3.4 Oracle Corporation Revenue in Pharmacovigilance (PV) and Drug Safety Software Business (2019-2024)
11.3.5 Oracle Corporation Recent Development
11.4 EXTEDO GmbH
11.4.1 EXTEDO GmbH Company Detail
11.4.2 EXTEDO GmbH Business Overview
11.4.3 EXTEDO GmbH Pharmacovigilance (PV) and Drug Safety Software Introduction
11.4.4 EXTEDO GmbH Revenue in Pharmacovigilance (PV) and Drug Safety Software Business (2019-2024)
11.4.5 EXTEDO GmbH Recent Development
11.5 Ennov Solutions, Inc.
11.5.1 Ennov Solutions, Inc. Company Detail
11.5.2 Ennov Solutions, Inc. Business Overview
11.5.3 Ennov Solutions, Inc. Pharmacovigilance (PV) and Drug Safety Software Introduction
11.5.4 Ennov Solutions, Inc. Revenue in Pharmacovigilance (PV) and Drug Safety Software Business (2019-2024)
11.5.5 Ennov Solutions, Inc. Recent Development
11.6 ArisGlobal
11.6.1 ArisGlobal Company Detail
11.6.2 ArisGlobal Business Overview
11.6.3 ArisGlobal Pharmacovigilance (PV) and Drug Safety Software Introduction
11.6.4 ArisGlobal Revenue in Pharmacovigilance (PV) and Drug Safety Software Business (2019-2024)
11.6.5 ArisGlobal Recent Development
11.7 United BioSource Corporation
11.7.1 United BioSource Corporation Company Detail
11.7.2 United BioSource Corporation Business Overview
11.7.3 United BioSource Corporation Pharmacovigilance (PV) and Drug Safety Software Introduction
11.7.4 United BioSource Corporation Revenue in Pharmacovigilance (PV) and Drug Safety Software Business (2019-2024)
11.7.5 United BioSource Corporation Recent Development
11.8 Online Business Applications, Inc.
11.8.1 Online Business Applications, Inc. Company Detail
11.8.2 Online Business Applications, Inc. Business Overview
11.8.3 Online Business Applications, Inc. Pharmacovigilance (PV) and Drug Safety Software Introduction
11.8.4 Online Business Applications, Inc. Revenue in Pharmacovigilance (PV) and Drug Safety Software Business (2019-2024)
11.8.5 Online Business Applications, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
